heme arginate

DRUG7 trials

Sponsors

National Center for Research Resources (NCRR), University Medical Center Groningen, Daniel Doberer, University of Edinburgh

Conditions

Acute Kidney InjuryAcute Myocardial InfarctionGenetic PolymorphismHealthy SubjectsHeme OxygenasePorphyria

Phase 1

Phase I Study of Tin Mesoporphyrin in Patients on Long Term Heme Therapy for Prevention of Acute Attacks of Porphyria

CompletedNCT00004397

National Center for Research Resources (NCRR)Porphyria

Start: 1998-01-31End: 2000-05-31Target: 20Updated: 2005-06-24

Phase I Study of Heme Arginate With or Without Tin Mesoporphyrin in Patients With Acute Attacks of Porphyria

CompletedNCT00004398

National Center for Research Resources (NCRR)Porphyria

Start: 1998-01-31End: 2000-05-31Target: 24Updated: 2005-06-24

Phase I/II Study of Heme Arginate and Tin Mesoporphyrin for Acute Porphyria

CompletedNCT00004789

National Center for Research Resources (NCRR)Porphyria

Start: 1993-07-31Target: 59Updated: 2005-06-24

Does Heme Oxygenase-1 Induction Ameliorate Cardiac Injury After Myocardial Infarction?

CompletedNCT00483587

University Medical Center GroningenAcute Myocardial Infarction

Start: 2007-07-31End: 2010-02-28Updated: 2010-09-20

Effects of Heme Arginate in Healthy Male Subjects

CompletedNCT00682370

Daniel DobererGenetic Polymorphism, Healthy Subjects, Heme Oxygenase

Start: 2007-10-31End: 2008-07-31Updated: 2013-01-15

Phase 2

Studies in Porphyria III: Heme and Tin Mesoporphyrin in Acute Porphyrias

CompletedNCT00004396

National Center for Research Resources (NCRR)Porphyria

Start: 1997-09-30Target: 32Updated: 2005-06-24

Heme Arginate in Cardiac Surgery Patients

CompletedNCT02142699

University of EdinburghAcute Kidney Injury

Start: 2014-10-17End: 2015-11-16Updated: 2024-09-19